Chronic Kidney Disease (CKD) Algorithm - NHS Cumbria

Box 5 - Reduce cardiovasculardisease risk• Offer statins for the primary prevention ofcardiovascular disease in the same way asin people without CKD• Use statins for the secondary preventionof cardiovascular disease irrespective ofbaseline lipids. Use statins in people withdiabetes (NCG67) 7• Patients with CKD are at high risk ofcardiovascular disease. The Framinghamrisk tables significantly underestimate CVrisk. All should be considered for statinstaking into account individual factors• Use antiplatelet drugs for the secondaryprevention of cardiovascular diseaseBox 6 - Identify progressive CKD(NCG 73 p5)• Define progressive as a decline in eGFR of>5ml/min per year, or >10ml/min in 5 years- For a new finding of reduced eGFR,repeat test within 2 weeks to excludeacute kidney injury- To identify progression take at least 3eGFRs over at least 90 days- Consider whether progression at theobserved rate would lead to renalreplacement therapy within the person’slifetime• Chronic use of NSAIDs may be associatedwith progression; exercise caution andmonitor GFR annually in those taking themlong-termChronic Kidney Disease (CKD) Algorithm | Page 7